MAIA
MAIA Biotechnology, Inc.
Price Chart
Latest Quote
$1.39
+0.01 (+0.72%)
Current Price
| Previous Close | $1.38 |
| Open | $1.40 |
| Day High | $1.48 |
| Day Low | $1.38 |
| Volume | 636,217 |
Stock Information
| Shares Outstanding | 60.80M |
| Cash Equivalents | $34.41M |
| Net Income | $-24.25M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $84.51M |
| EPS (TTM) | $-0.68 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $50.10M |
| Income | $-24.25M |
| Book/sh | $0.46 |
| Cash/sh | $0.57 |
| Employees | 13 |
Financial Ratios
| Quick Ratio | 5.44 |
| Current Ratio | 5.59 |
Returns & Margins
| ROA | -68.33% |
| ROE | -148.29% |
Ownership
| Insider Ownership | 14.39% |
| Institutional Ownership | 21.63% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 1.24 |
| P/B | 3.03 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $12.13 |
Technical Indicators
| SMA20 | $1.35 |
| SMA50 | $1.33 |
| SMA200 | $1.50 |
| RSI | 46.67 |
| ATR | 0.0975 |
| Shares Float | 51.28M |
| Short Float | 5.30% |
| Short Ratio | 5.13 |
| Volatility | 0.24 |
| Rel Volume | 0.61 |
Performance History
| Week | +5.30% |
| Month | +8.59% |
| Quarter | -3.47% |
| 6 Months | +13.93% |
| YTD | -13.13% |
| Year | -19.65% |
| 3 Years | -40.34% |
| 10 Years | -68.83% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.39 | 648,300 |
| 2026-06-23 | $1.38 | 460,900 |
| 2026-06-22 | $1.38 | 445,700 |
| 2026-06-18 | $1.40 | 1,381,200 |
| 2026-06-17 | $1.32 | 449,600 |
| 2026-06-16 | $1.32 | 358,100 |
| 2026-06-15 | $1.36 | 1,126,800 |
| 2026-06-12 | $1.30 | 399,700 |
| 2026-06-11 | $1.30 | 726,600 |
| 2026-06-10 | $1.27 | 973,600 |
| 2026-06-09 | $1.30 | 612,400 |
| 2026-06-08 | $1.27 | 616,100 |
| 2026-06-05 | $1.36 | 1,449,700 |
| 2026-06-04 | $1.50 | 3,329,900 |
| 2026-06-03 | $1.43 | 2,208,500 |
| 2026-06-02 | $1.35 | 3,439,000 |
| 2026-06-01 | $1.30 | 767,100 |
| 2026-05-29 | $1.39 | 1,118,100 |
| 2026-05-28 | $1.29 | 376,500 |
| 2026-05-27 | $1.31 | 320,300 |
| 2026-05-26 | $1.33 | 526,200 |
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
đ° Latest News
Sector Update: Healthcare Stocks Higher Late Afternoon
MT Newswires âĸ 2026-06-03T19:43:58ZCancer drug maker takes sudden pivot into crypto
TheStreet âĸ 2025-10-07T19:13:11Z
Maiaâs NSCLC immunotherapy secures Phase II efficacy win
Clinical Trials Arena âĸ 2025-09-12T12:33:25Z
MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial
Clinical Trials Arena âĸ 2025-07-10T14:40:41Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $0 | $57 | $6,863 | $6,967 |
| Total Expenses | $23,908,336 | $16,877,256 | $20,005,662 | $15,862,576 |
| Other Income Expense | $1,198,210 | $-6,695,710 | $205,130 | $98,394 |
| Net Non Operating Interest Income Expense | $313,954 | $318,310 | $27,627 | $-5,097 |
| Interest Expense Non Operating | $0 | $57 | $6,863 | $6,967 |
| Operating Expense | $23,908,336 | $16,877,256 | $20,005,662 | $15,862,576 |
| Other Operating Expenses | $-361,350 | $-79,954 | $-176,719 | $785,735 |
| General And Administrative Expense | $9,722,354 | $6,947,981 | $9,070,124 | $6,143,527 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Net Interest Income | $313,954 | $318,310 | $27,627 | $-5,097 |
| Interest Income | $313,954 | $318,367 | $34,490 | $1,870 |
| Normalized Income | $-23,594,382 | $-16,558,946 | $-19,978,035 | $-15,867,673 |
| Net Income From Continuing And Discontinued Operation | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Total Operating Income As Reported | $-24,269,686 | $-16,957,210 | $-20,182,381 | $-16,176,201 |
| Net Income Common Stockholders | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-16,219,857 |
| Net Income | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Net Income Including Noncontrolling Interests | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Net Income Continuous Operations | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Pretax Income | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Interest Income Non Operating | $313,954 | $318,367 | $34,490 | $1,870 |
| Operating Income | $-23,908,336 | $-16,877,256 | $-20,005,662 | $-15,862,576 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.70 | $-1.05 | $-1.49 | $-1.75 |
| Basic EPS | $-0.70 | $-1.05 | $-1.49 | $-1.75 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-23,594,382 | $-16,558,889 | $-19,971,172 | $-15,860,706 |
| Total Unusual Items | $1,198,210 | $-6,695,710 | $205,130 | $98,394 |
| Total Unusual Items Excluding Goodwill | $1,198,210 | $-6,695,710 | $205,130 | $98,394 |
| EBITDA (Bullshit earnings) | $-22,396,172 | $-23,254,599 | $-19,766,042 | $-15,762,312 |
| EBIT | $-22,396,172 | $-23,254,599 | $-19,766,042 | $-15,762,312 |
| Diluted Average Shares | $32,114,608 | $22,197,517 | $13,261,572 | $9,276,761 |
| Basic Average Shares | $32,114,608 | $22,197,517 | $13,261,572 | $9,276,761 |
| Diluted NI Availto Com Stockholders | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-16,219,857 |
| Gain On Sale Of Security | $1,198,210 | $-6,695,710 | $205,130 | $98,394 |
| Research And Development | $14,547,332 | $10,009,229 | $11,112,257 | $8,933,314 |
| Selling General And Administration | $9,722,354 | $6,947,981 | $9,070,124 | $6,143,527 |
| Other Gand A | $9,722,354 | $6,947,981 | $9,070,124 | $6,143,527 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $450,578 |
| Minority Interests | - | - | - | $0 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Total Assets | $9,704,656 | $10,155,279 | $7,566,852 | $12,022,040 |
| Total Non Current Assets | $2,800 | $2,800 | $2,800 | $214,003 |
| Other Non Current Assets | $2,800 | $2,800 | $2,800 | $2,800 |
| Current Assets | $9,701,856 | $10,152,479 | $7,564,052 | $11,808,037 |
| Other Current Assets | $1,043,825 | $473,834 | $268,677 | $554,321 |
| Receivables | $0 | $77,347 | $144,680 | $302,789 |
| Cash Cash Equivalents And Short Term Investments | $8,658,031 | $9,601,298 | $7,150,695 | $10,950,927 |
| Cash And Cash Equivalents | $8,658,031 | $9,601,298 | $7,150,695 | $10,950,927 |
| Cash Financial | $8,658,031 | $9,601,298 | $7,150,695 | $10,950,927 |
| Other Receivables | - | $77,347 | $144,680 | $302,789 |
| Non Current Deferred Assets | - | - | $0 | $211,203 |
| Prepaid Assets | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,328,793 | $6,520,643 | $7,089,341 | $3,514,247 |
| Total Non Current Liabilities Net Minority Interest | $1,492,395 | $2,690,605 | $2,152,188 | $245,341 |
| Derivative Product Liabilities | $1,492,395 | $2,690,605 | $2,152,188 | $245,341 |
| Current Liabilities | $5,836,398 | $3,830,038 | $4,937,153 | $3,268,906 |
| Payables And Accrued Expenses | $4,636,443 | $2,888,940 | $3,325,719 | $2,174,324 |
| Payables | $2,038,803 | $1,512,436 | $1,638,546 | $1,165,505 |
| Accounts Payable | $2,038,803 | $1,512,436 | $1,638,546 | $1,165,505 |
| Current Deferred Liabilities | - | - | - | $0 |
| Interest Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Total Equity Gross Minority Interest | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Stockholders Equity | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Gains Losses Not Affecting Retained Earnings | $-50,228 | $-30,615 | $-16,260 | $-15,973 |
| Other Equity Adjustments | $-50,228 | $-30,615 | $-16,260 | $-15,973 |
| Retained Earnings | $-109,631,005 | $-87,234,833 | $-63,980,177 | $-44,207,272 |
| Other | ||||
| Ordinary Shares Number | $38,624,289 | $26,157,788 | $16,986,254 | $10,955,904 |
| Share Issued | $38,624,289 | $26,157,788 | $16,986,254 | $10,955,904 |
| Tangible Book Value | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Invested Capital | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Working Capital | $3,865,458 | $6,322,441 | $2,626,899 | $8,539,131 |
| Total Capitalization | $2,375,863 | $3,634,636 | $477,511 | $8,507,793 |
| Additional Paid In Capital | $112,053,233 | $90,897,468 | $64,472,249 | $52,729,942 |
| Capital Stock | $3,863 | $2,616 | $1,699 | $1,096 |
| Common Stock | $3,863 | $2,616 | $1,699 | $1,096 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,199,955 | $941,098 | $1,611,434 | $1,094,582 |
| Current Accrued Expenses | $2,597,640 | $1,376,504 | $1,687,173 | $1,008,819 |
| Treasury Shares Number | - | - | $0 | - |
| Minority Interest | - | - | - | - |
| Dueto Related Parties Current | - | - | - | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-18,844,598 | $-15,704,461 | $-13,071,016 | $-12,096,104 |
| Operating Activities | ||||
| Operating Cash Flow | $-18,844,598 | $-15,704,461 | $-13,071,016 | $-12,096,104 |
| Cash Flow From Continuing Operating Activities | $-18,844,598 | $-15,704,461 | $-13,071,016 | $-12,096,104 |
| Operating Gains Losses | $-1,198,210 | $6,695,710 | $-205,130 | $-98,394 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $17,621,258 | $18,754,708 | $11,416,960 | $13,973,560 |
| Financing Cash Flow | $17,906,547 | $18,176,609 | $9,270,901 | $12,477,169 |
| Cash Flow From Continuing Financing Activities | $17,906,547 | $18,176,609 | $9,270,901 | $12,477,169 |
| Net Other Financing Charges | $-617,133 | $-795,257 | $-2,147,491 | $-1,965,791 |
| Net Common Stock Issuance | $17,621,258 | $18,754,708 | $11,416,960 | $13,973,560 |
| Common Stock Issuance | $17,621,258 | $18,754,708 | $11,416,960 | $13,973,560 |
| Other | ||||
| End Cash Position | $8,658,031 | $9,601,298 | $7,150,695 | $10,950,927 |
| Beginning Cash Position | $9,601,298 | $7,150,695 | $10,950,927 | $10,574,292 |
| Effect Of Exchange Rate Changes | $-5,216 | $-21,545 | $-117 | $-4,430 |
| Changes In Cash | $-938,051 | $2,472,148 | $-3,800,115 | $381,065 |
| Proceeds From Stock Option Exercised | $902,422 | $217,158 | $1,432 | $469,400 |
| Change In Working Capital | $1,499,319 | $-1,237,749 | $3,086,054 | $352,782 |
| Change In Payables And Accrued Expense | $1,998,675 | $-1,098,619 | $2,641,818 | $1,127,088 |
| Change In Accrued Expense | $1,478,955 | $-979,792 | $2,169,921 | $915,742 |
| Change In Payable | $519,720 | $-118,827 | $471,897 | $211,346 |
| Change In Account Payable | $519,720 | $-118,827 | $471,897 | $211,346 |
| Change In Prepaid Assets | $-579,766 | $-195,935 | $285,831 | $-505,233 |
| Change In Receivables | $80,410 | $56,805 | $158,405 | $-269,395 |
| Other Non Cash Items | $618,813 | $179,490 | $731,661 | $1,099,360 |
| Stock Based Compensation | $2,631,652 | $1,912,744 | $3,089,304 | $2,319,427 |
| Gain Loss On Investment Securities | $-1,198,210 | $6,695,710 | $-205,130 | $-98,394 |
| Net Income From Continuing Operations | $-22,396,172 | $-23,254,656 | $-19,772,905 | $-15,769,279 |
| Change In Other Current Assets | - | - | $0 | $322 |
| Repayment Of Debt | - | - | - | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $440,379 |
Fetched: 2026-06-15